Biotechnology AXSM INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Axsome Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit May 26, 2022
Biotechnology Galapagos to showcase commitment to rheumatoid arthritis care at the upcoming European League Against Rheumatism congress May 25, 2022
Biotechnology The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BKKT, UPST and AXSM May 25, 2022
Biotechnology GLOBAL STUDY DEMONSTRATES ICE3 AND MAURICE CAPILLARY ISOELECTRIC FOCUSING COMPARABILITY IN THE JOURNAL OF ELECTROPHERESIS May 25, 2022
Health The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ABBV, AXSM and CDNA May 24, 2022